|
KMID : 0379520020180030249
|
|
한국독성학회지
2002 Volume.18 No. 3 p.249 ~ p.257
|
|
|
Molecular Cloning and Expression of Fusion Proteins Containing Human Cytochrome P450 3As and Rat NADPH-P450 Reductase in Escherichia coli
|
|
Chun Young-Jin
Guengerich F-Peter
|
|
|
Abstract
|
|
|
|
Cytochrome P450 3As such as 3A4 and 3A5 metabolize a wide range of pharmaceutical compounds. The vectors for the expression of fusion protein containing an N-terminal human P450 3A4 or P450 3A5 sequences and a C-terminal rat NADPH-cytochrome P450 reductase moiety were constructed. These plasmids were used to express the fusion protein in Escherichia coli DH5alpha cells. High levels of expression were achieved (100~200 nmol/liter) and the expressed fusion protein in E. coli membranes were catalytically active for nifedipine oxidation, a typical enzymatic activity of P450 3A4. The NADPH-P450 reductase activities of these fusion protein were also determined by measuring reduction of cytochrome c. To fine a specific Inhibitor of P450 3A4 from naturally occurring chemicals, a series of isothiocyanate compounds were evaluated for the inhibitory activity of P450 using the fusion proteins in E. coli membranes. Of the five isothiocyanates (phenethyl isothiocyanate, phenyl isothiocyanate, benzol isothiocyanate, benzoyl isothiocyanate and cyclohexyl isothiocyanate) tested, benzoyl isothiocyanate showed a strong inhibition of P450 3A4 with an IC_{50}value of 2.8 mutextrm{M}. Our results indicate that the self-sufficient fusion protein will be very useful tool to study the drug metabolism and benzyl isothiocyanate may be valuable for characterizing the enzymatic properties of P450 3A4.
|
|
|
KEYWORD
|
|
|
Cytochrome P450 3A4, Cytochrome P450 3A5, NADPH-P450 reductase, Heterologous expression, Fusion protein, Benzoyl isothiocyanate
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|